Cambridge Antibody (LSE:CAT; CATG) and AstraZeneca (LSE:AZN; AZN) partnered to discover and develop monoclonal antibodies to treat inflammatory and respiratory diseases. CAT is responsible for antibody discovery
Read the full 272 word article
User Sign In
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury